Go Pro

NexGel (NXGL) Competitors

NexGel logo
$0.35 0.00 (0.00%)
Closing price 08/28/2026 04:00 PM Eastern
Extended Trading
$0.34 -0.01 (-3.41%)
As of 05:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

NXGL vs. LUCY, BMRA, CUPR, LUCYW, and NXGLW

Should you buy NexGel stock or one of its competitors? NexGel's main competitors and comparable companies include Innovative Eyewear (LUCY), Biomerica (BMRA), Cuprina Holdings (Cayman) (CUPR), Innovative Eyewear (LUCYW), and NEXGEL (NXGLW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does NexGel compare to Innovative Eyewear?

NexGel (NASDAQ:NXGL) and Innovative Eyewear (NASDAQ:LUCY) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, analyst recommendations, profitability, dividends and earnings.

NexGel presently has a consensus target price of $2.00, suggesting a potential upside of 468.18%. Given NexGel's higher probable upside, equities research analysts clearly believe NexGel is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NexGel
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Innovative Eyewear
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, Innovative Eyewear had 13 more articles in the media than NexGel. MarketBeat recorded 17 mentions for Innovative Eyewear and 4 mentions for NexGel. NexGel's average media sentiment score of -0.28 beat Innovative Eyewear's score of -0.42 indicating that NexGel is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
NexGel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Innovative Eyewear
2 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NexGel has a net margin of -51.26% compared to Innovative Eyewear's net margin of -225.26%. Innovative Eyewear's return on equity of -88.90% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
NexGel-51.26% -121.18% -41.15%
Innovative Eyewear -225.26%-88.90%-80.34%

2.2% of NexGel shares are held by institutional investors. Comparatively, 1.0% of Innovative Eyewear shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Comparatively, 1.7% of Innovative Eyewear shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

NexGel has higher revenue and earnings than Innovative Eyewear. Innovative Eyewear is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexGel$12.07M0.28-$3M-$0.71N/A
Innovative Eyewear$3.41M2.40-$7.59M-$1.29N/A

NexGel has a beta of 0.78, suggesting that its share price is 22% less volatile than the broader market. Comparatively, Innovative Eyewear has a beta of 2.72, suggesting that its share price is 172% more volatile than the broader market.

Summary

NexGel beats Innovative Eyewear on 10 of the 14 factors compared between the two stocks.

How does NexGel compare to Biomerica?

Biomerica (NASDAQ:BMRA) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their valuation, analyst recommendations, risk, media sentiment, dividends, earnings, institutional ownership and profitability.

NexGel has a net margin of -51.26% compared to Biomerica's net margin of -96.49%. Biomerica's return on equity of -98.14% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
Biomerica-96.49% -98.14% -70.42%
NexGel -51.26%-121.18%-41.15%

22.3% of Biomerica shares are held by institutional investors. Comparatively, 2.2% of NexGel shares are held by institutional investors. 18.0% of Biomerica shares are held by insiders. Comparatively, 23.4% of NexGel shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

NexGel has higher revenue and earnings than Biomerica. Biomerica is trading at a lower price-to-earnings ratio than NexGel, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Biomerica$5.31M1.25-$4.97M-$0.89N/A
NexGel$12.07M0.28-$3M-$0.71N/A

Biomerica has a beta of 0.35, suggesting that its stock price is 65% less volatile than the broader market. Comparatively, NexGel has a beta of 0.78, suggesting that its stock price is 22% less volatile than the broader market.

In the previous week, Biomerica had 4 more articles in the media than NexGel. MarketBeat recorded 8 mentions for Biomerica and 4 mentions for NexGel. Biomerica's average media sentiment score of 1.22 beat NexGel's score of -0.28 indicating that Biomerica is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Biomerica
2 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NexGel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Biomerica currently has a consensus price target of $9.00, suggesting a potential upside of 320.56%. NexGel has a consensus price target of $2.00, suggesting a potential upside of 468.18%. Given NexGel's stronger consensus rating and higher possible upside, analysts plainly believe NexGel is more favorable than Biomerica.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Biomerica
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NexGel
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

NexGel beats Biomerica on 10 of the 15 factors compared between the two stocks.

How does NexGel compare to Cuprina Holdings (Cayman)?

Cuprina Holdings (Cayman) (NASDAQ:CUPR) and NexGel (NASDAQ:NXGL) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, dividends and earnings.

2.2% of NexGel shares are owned by institutional investors. 23.4% of NexGel shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Cuprina Holdings (Cayman) has a beta of -0.35, meaning that its share price is 135% less volatile than the broader market. Comparatively, NexGel has a beta of 0.78, meaning that its share price is 22% less volatile than the broader market.

Cuprina Holdings (Cayman) has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Cuprina Holdings (Cayman)'s return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
Cuprina Holdings (Cayman)N/A N/A N/A
NexGel -51.26%-121.18%-41.15%

NexGel has higher revenue and earnings than Cuprina Holdings (Cayman).

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cuprina Holdings (Cayman)$40K69.23-$3.63MN/AN/A
NexGel$12.07M0.28-$3M-$0.71N/A

NexGel has a consensus target price of $2.00, indicating a potential upside of 468.18%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than Cuprina Holdings (Cayman).

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cuprina Holdings (Cayman)
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
NexGel
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

In the previous week, NexGel had 2 more articles in the media than Cuprina Holdings (Cayman). MarketBeat recorded 4 mentions for NexGel and 2 mentions for Cuprina Holdings (Cayman). Cuprina Holdings (Cayman)'s average media sentiment score of 1.43 beat NexGel's score of -0.28 indicating that Cuprina Holdings (Cayman) is being referred to more favorably in the media.

Company Overall Sentiment
Cuprina Holdings (Cayman) Positive
NexGel Neutral

Summary

NexGel beats Cuprina Holdings (Cayman) on 8 of the 13 factors compared between the two stocks.

How does NexGel compare to Innovative Eyewear?

Innovative Eyewear (NASDAQ:LUCYW) and NexGel (NASDAQ:NXGL) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, institutional ownership, dividends, valuation, analyst recommendations, profitability, media sentiment and risk.

2.2% of NexGel shares are held by institutional investors. 23.4% of NexGel shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, NexGel had 2 more articles in the media than Innovative Eyewear. MarketBeat recorded 4 mentions for NexGel and 2 mentions for Innovative Eyewear. Innovative Eyewear's average media sentiment score of 1.06 beat NexGel's score of -0.28 indicating that Innovative Eyewear is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Innovative Eyewear
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
NexGel
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

NexGel has a consensus target price of $2.00, indicating a potential upside of 468.18%. Given NexGel's stronger consensus rating and higher possible upside, analysts clearly believe NexGel is more favorable than Innovative Eyewear.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Innovative Eyewear
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
NexGel
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Innovative Eyewear has higher earnings, but lower revenue than NexGel.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Innovative Eyewear$3.41MN/AN/AN/AN/A
NexGel$12.07M0.28-$3M-$0.71N/A

Innovative Eyewear has a net margin of 0.00% compared to NexGel's net margin of -51.26%. Innovative Eyewear's return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
Innovative EyewearN/A N/A N/A
NexGel -51.26%-121.18%-41.15%

Summary

NexGel beats Innovative Eyewear on 6 of the 10 factors compared between the two stocks.

How does NexGel compare to NEXGEL?

NexGel (NASDAQ:NXGL) and NEXGEL (NASDAQ:NXGLW) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations, media sentiment and valuation.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
NexGel$12.07M0.28-$3M-$0.71N/A
NEXGEL$12.07MN/AN/AN/AN/A

2.2% of NexGel shares are owned by institutional investors. 23.4% of NexGel shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

NEXGEL has a net margin of 0.00% compared to NexGel's net margin of -51.26%. NEXGEL's return on equity of 0.00% beat NexGel's return on equity.

Company Net Margins Return on Equity Return on Assets
NexGel-51.26% -121.18% -41.15%
NEXGEL N/A N/A N/A

NexGel presently has a consensus target price of $2.00, indicating a potential upside of 468.18%. Given NexGel's stronger consensus rating and higher possible upside, equities research analysts plainly believe NexGel is more favorable than NEXGEL.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
NexGel
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
NEXGEL
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

In the previous week, NexGel had 2 more articles in the media than NEXGEL. MarketBeat recorded 4 mentions for NexGel and 2 mentions for NEXGEL. NEXGEL's average media sentiment score of 0.44 beat NexGel's score of -0.28 indicating that NEXGEL is being referred to more favorably in the news media.

Company Overall Sentiment
NexGel Neutral
NEXGEL Neutral

Summary

NexGel beats NEXGEL on 5 of the 9 factors compared between the two stocks.

Get NexGel News Delivered to You Automatically

Sign up to receive the latest news and ratings for NXGL and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding NXGL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NXGL vs. The Competition

MetricNexGelHealthcare Equipment & Supplies IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.43M$5.78B$7.18B$12.89B
Dividend YieldN/A1.75%2.54%11.27%
P/E Ratio-0.5025.92273.1725.45
Price / Sales0.2878.92638.21103.75
Price / CashN/A33.6928.7436.03
Price / Book0.596.1811.086.36
Net Income-$3M$149.94M$3.48B$349.79M
7 Day Performance-7.37%-0.22%0.38%-0.40%
1 Month Performance-15.20%6.39%7.89%4.24%
1 Year Performance-85.63%6.29%24.71%15.13%

NexGel Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NXGL
NexGel
2.1488 of 5 stars
$0.35
flat
$2.00
+468.2%
-85.6%$3.43M$12.07MN/A10
LUCY
Innovative Eyewear
1.0093 of 5 stars
$1.13
+5.6%
N/A-50.8%$9.21M$2.66MN/A9
BMRA
Biomerica
3.5041 of 5 stars
$1.69
-4.5%
$9.00
+432.6%
-31.6%$5.47M$5.31MN/A60
CUPR
Cuprina Holdings (Cayman)
1.0379 of 5 stars
$2.94
+0.7%
N/AN/A$2.69M$49.89KN/A14
LUCYW
Innovative Eyewear
N/A$0.04
-0.2%
N/A-58.5%$0.00$3.41MN/A9

Related Companies and Tools


This page (NASDAQ:NXGL) was last updated on 8/31/2026 by MarketBeat.com Staff.
From Our Partners